⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25207633 | 0.80 | — | — | |
| SCHEMBL5905827 | 0.80 | — | — | |
| Ammonia Solution, Strong SCHEMBL28150438 | 0.76 | — | — | |
| SCHEMBL1704673 | 0.75 | — | — | |
| SCHEMBL17642249 | 0.75 | — | — | |
| SCHEMBL8644424 | 0.73 | — | — | |
| SCHEMBL8375201 | 0.72 | — | — | |
| SCHEMBL8373194 | 0.70 | — | — | |
| SCHEMBL27527073 | 0.70 | TSHR (0.31) | — | |
| SCHEMBL1668124 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5990102-A | Substituted azetidin-2-ones for treatment of atherosclerosis | SMITHKLINE BEECHAM P.L.C. (GB) | 1999-11-23 | — | — | US | claimed |
| WO-1996019451-A1 | SUBSTITUTED AZETIDIN-2-ONES FOR TREATMENT OF ATHEROSCLEROSIS | SMITHKLINE BEECHAM PLC (GB) | 1996-06-27 | — | — | WO | claimed |
| CN-120202321-A | Inhibited atomic layer deposition for patterning applications | 朗姆研究公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-118541781-A | Carbon mask deposition | 朗姆研究公司 | 2024-08-23 | — | — | CN | disclosed |
| EP-0719839-B1 | Phthalocyanine compounds and optical recording media comprising them | MITSUI CHEMICALS INC (JP) | 2001-07-25 | — | — | EP | disclosed |
| US-5990102-A | Substituted azetidin-2-ones for treatment of atherosclerosis | SMITHKLINE BEECHAM P.L.C. (GB) | 1999-11-23 | — | — | US | disclosed |
| EP-0929560-A1 | CHIRAL FERROCENYLS | Novartis AG (CH) | 1999-07-21 | — | — | EP | disclosed |
| WO-1998015565-A1 | CHIRAL FERROCENYLS | NOVARTIS AG (CH) | 1998-04-16 | — | — | WO | disclosed |
| US-5693396-A | NEAR INFRARED LIGHT ABSORBERS | MITSUI TOATSU CHEMICALS, INC. (JP) | 1997-12-02 | — | — | US | disclosed |
| EP-0719839-A2 | Phthalocyanine compounds and optical recording media comprising them | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1996-07-03 | — | — | EP | disclosed |
| WO-1996019451-A1 | SUBSTITUTED AZETIDIN-2-ONES FOR TREATMENT OF ATHEROSCLEROSIS | SMITHKLINE BEECHAM PLC (GB) | 1996-06-27 | — | — | WO | disclosed |